Schmitz G, Assmann G
J Lipid Res. 1982 Aug;23(6):903-10.
High density lipoprotein subfraction-1 (HDL(1)) is thought to interact with the high-affinity apoprotein B, E receptors of peripheral cells and may act as a modulator of LDL binding and uptake. In the present study the concentration and composition of HDL(1) in normal and hypercholesterolemic sera were studied using zonal ultracentrifugation. To permit separation of the HDL(1) from VLDL, LDL, and Lp(a), the apoB-containing lipoproteins were first precipitated from serum using the phosphotungstic acid/magnesium chloride (PTA/MgCl(2)) method after which the supernatant fraction was subjected to zonal ultracentrifugation. It could be demonstrated that following PTA/MgCl(2) precipitation HDL(1) floats as a single peak at d 1.08-1.09 g/ml (NaBr) and is sufficiently separated from high density lipoprotein-2 (HDL(2)) and high density lipoprotein-3 (HDL(3)). The HDL(2)/HDL(3) subfraction pattern was not affected by the precipitation method. As previously described, in vitro incubation of serum leads to the LCAT-dependent interconversion of HDL(3) or HDL(2). Using the technique described here, it was discovered that a simultaneous elevation of HDL(1) occurred. This increase in HDL(1) concentration could not be observed when LCAT was inhibited by heat inactivation or addition of Ellman's reagent. In normal fresh serum only a small HDL(1) peak could be detected, but in patients with familial hypercholesterolemia (apoB, E receptor deficiency) HDL(1) was elevated five to tenfold compared to normal values and further increased in concentration upon incubation of serum. On the other hand, in sera of patients with familial HDL deficiency (Tangier disease), HDL(1) was undetectable. Analysis of the HDL fractions in serum of a patient with abetalipoproteinemia revealed that following in vitro incubation there was formation of HDL(1) despite the lack of apoprotein B-containing lipoproteins. These data support the concept that HDL(1) formation occurs during LCAT-mediated HDL(3)/HDL(2) interconversion in vitro.-Schmitz, G., and G. Assmann. Isolation of human serum HDL(1) by zonal ultracentrifugation.
高密度脂蛋白亚组分-1(HDL(1))被认为可与外周细胞的高亲和力载脂蛋白B、E受体相互作用,并可能作为低密度脂蛋白(LDL)结合和摄取的调节剂。在本研究中,使用区带超速离心法研究了正常血清和高胆固醇血症血清中HDL(1)的浓度和组成。为了将HDL(1)与极低密度脂蛋白(VLDL)、LDL和脂蛋白(a)(Lp(a))分离,首先使用磷钨酸/氯化镁(PTA/MgCl(2))法从血清中沉淀出含载脂蛋白B的脂蛋白,然后将上清液进行区带超速离心。结果表明,经PTA/MgCl(2)沉淀后,HDL(1)在d 1.08 - 1.09 g/ml(溴化钠)处作为单一峰漂浮,并且与高密度脂蛋白-2(HDL(2))和高密度脂蛋白-3(HDL(3))充分分离。HDL(2)/HDL(3)亚组分模式不受沉淀方法的影响。如前所述,血清的体外孵育会导致HDL(3)或HDL(2)发生卵磷脂胆固醇酰基转移酶(LCAT)依赖性的相互转化。使用此处描述的技术发现,同时出现了HDL(1)升高。当通过热失活或添加埃尔曼试剂抑制LCAT时,未观察到HDL(1)浓度的这种增加。在正常新鲜血清中仅可检测到一个小的HDL(1)峰,但在家族性高胆固醇血症(载脂蛋白B、E受体缺陷)患者中,HDL(1)比正常值升高了五到十倍,并且在血清孵育后浓度进一步增加。另一方面,在家族性HDL缺乏症(丹吉尔病)患者的血清中,未检测到HDL(1)。对一名无β脂蛋白血症患者血清中HDL组分的分析表明,尽管缺乏含载脂蛋白B的脂蛋白,但体外孵育后仍形成了HDL(1)。这些数据支持了HDL(1)的形成发生在体外LCAT介导的HDL(3)/HDL(2)相互转化过程中的观点。——施密茨,G.,和G. 阿斯曼。通过区带超速离心法分离人血清HDL(1)